MSB have multiple treatments in phase three trials right now which differentiate them from Eton so you can't compare two completely different companies SP.
Tomorrow is quite literally history in the making for medicine and MSB. An FDA approval reduces the stigma around MSCs in the States and it paves the way for other stem cell therapy approvals. If the FDA approval goes our way, this is the start of the stars aligning for MSB to be the next Aussie biotech success story, I truly believe that.
GLTAH and DYOR!!! Going to be difficult sleeping tonight!!!
MSB have multiple treatments in phase three trials right now...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |